Neurocrine Biosciences Current Ratio 2010-2024 | NBIX

Neurocrine Biosciences current ratio for the quarter ending September 30, 2024 was 4.37.

  • Neurocrine Biosciences average current ratio for 2023 was 2.81, a 11.91% increase from 2022.
  • Neurocrine Biosciences average current ratio for 2022 was 3.19, a 33.95% decline from 2021.
  • Neurocrine Biosciences average current ratio for 2021 was 4.83, a 18.97% decline from 2020.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.

Neurocrine Biosciences Current Ratio 2010-2024 | NBIX

  • Neurocrine Biosciences average current ratio for 2023 was 2.81, a 11.91% increase from 2022.
  • Neurocrine Biosciences average current ratio for 2022 was 3.19, a 33.95% decline from 2021.
  • Neurocrine Biosciences average current ratio for 2021 was 4.83, a 18.97% decline from 2020.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.